ProfileGDS4718 / 232487_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 32% 19% 23% 19% 20% 22% 27% 16% 25% 18% 19% 19% 20% 30% 27% 30% 19% 22% 25% 17% 17% 26% 22% 27% 21% 23% 26% 26% 22% 16% 18% 17% 20% 30% 45% 28% 21% 22% 21% 19% 20% 13% 28% 30% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.6346932
GSM549102patient 115, normal, homogenized [OPG study]4.1289619
GSM549104patient 119, normal, homogenized [OPG study]4.229823
GSM549108patient 138, normal, homogenized [OPG study]4.1590819
GSM549119patient 077, normal, homogenized [OPG study]4.166320
GSM549133patient 032, cancer, homogenized [OPG study]4.188522
GSM549139patient 042, cancer, homogenized [OPG study]4.3946927
GSM549099patient 107, normal, homogenized [OPG study]4.0000516
GSM549109patient 139, normal, homogenized [OPG study]4.355325
GSM549110patient 046, normal, homogenized [OPG study]4.0768118
GSM549114patient 063, normal, homogenized [OPG study]4.0596919
GSM549122patient 082, normal, homogenized [OPG study]4.11519
GSM549134patient 033, cancer, homogenized [OPG study]4.15120
GSM549136patient 036, cancer, homogenized [OPG study]4.485330
GSM549140patient 044, cancer, homogenized [OPG study]4.3818327
GSM549111patient 047, normal, homogenized [OPG study]4.5298230
GSM549113patient 057, normal, homogenized [OPG study]4.0540319
GSM549132patient 031, cancer, homogenized [OPG study]4.2172522
GSM549137patient 038, cancer, homogenized [OPG study]4.3026325
GSM549142patient 047, cancer, homogenized [OPG study]4.1263617
GSM549100patient 110, normal, homogenized [OPG study]4.0330517
GSM549107patient 135, normal, homogenized [OPG study]4.349926
GSM549115patient 068, normal, homogenized [OPG study]4.1634422
GSM549116patient 072, normal, homogenized [OPG study]4.3860127
GSM549120patient 078, normal, homogenized [OPG study]4.170921
GSM549131patient 030, cancer, homogenized [OPG study]4.2042723
GSM549118patient 074, normal, homogenized [OPG study]4.3629526
GSM549129patient 027, cancer, homogenized [OPG study]4.4010526
GSM549123patient 088, normal, homogenized [OPG study]4.2025922
GSM549124patient 006, cancer, homogenized [OPG study]4.0565616
GSM549126patient 015, cancer, homogenized [OPG study]4.0444318
GSM549128patient 025, cancer, homogenized [OPG study]3.9932717
GSM549103patient 117, normal, homogenized [OPG study]4.1785120
GSM549117patient 073, normal, homogenized [OPG study]4.507130
GSM549138patient 041, cancer, homogenized [OPG study]5.2391445
GSM549141patient 045, cancer, homogenized [OPG study]4.3829628
GSM549130patient 028, cancer, homogenized [OPG study]4.1830221
GSM549101patient 111, normal, homogenized [OPG study]4.2449822
GSM549105patient 128, normal, homogenized [OPG study]4.183121
GSM549106patient 134, normal, homogenized [OPG study]4.0683519
GSM549112patient 048, normal, homogenized [OPG study]4.1542920
GSM549125patient 011, cancer, homogenized [OPG study]3.9046113
GSM549127patient 024, cancer, homogenized [OPG study]4.4304928
GSM549135patient 035, cancer, homogenized [OPG study]4.4723530